There were 131 press releases posted in the last 24 hours and 442,474 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Junshi Biosciences Announces Dosing of First Healthy Volunteer in Phase I Clinical Study of SARS-CoV-2 Neutralizing Antibody JS016 in China

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image